SEC filings
West Pharmaceutical Services (WST)
Recent filings West Pharmaceutical Services made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0000105770All filings on SEC.gov
10-QQuarterly report
Quarterly report
West Pharmaceutical Services reported third-quarter 2026 GAAP net income of $214.0 million, or $3.02 per diluted share, and adjusted net income of $188.8 million, or $2.66 per diluted share, compared with GAAP net income of $140.0 million…
8-KCurrent report
Results of Operations and Financial Condition; Regulation FD Disclosure
West Pharmaceutical Services reported third-quarter 2026 net sales of $874.5 million, up 8.7% year over year with 11.9% organic growth, and adjusted-diluted EPS of $2.66, up 35.7%, led by its High-Value Product Components business. …
8-KCurrent report
Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement …
West Pharmaceutical Services entered a new five-year credit agreement with Bank of America as administrative agent, providing a $750 million revolving facility and a $200 million term loan, and used part of the proceeds to repay the $130…
10-QQuarterly report
Quarterly report
For the quarter ended June 30, 2026, West Pharmaceutical Services reported GAAP diluted EPS of $2.15 and adjusted diluted EPS of $2.37, with six-month GAAP diluted EPS of $4.07 and adjusted diluted EPS of $4.50. …
8-KCurrent report
Results of Operations and Financial Condition; Regulation FD Disclosure
West Pharmaceutical Services reported strong second-quarter 2026 financial results, achieving net sales of $872.3 million and diluted earnings per share of $2.15. …
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow West Pharmaceutical Services in Readster
Add West Pharmaceutical Services to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.